Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptarro, formerly known as Alpha II, is a private healthcare technology company focused on revenue cycle management software for providers, health systems, billing organizations, clearinghouses, and government-related healthcare users. The company offers AI-powered coding, claims editing, denial prevention, reimbursement accuracy, compliance, and workflow automation solutions designed to improve clean-claim rates and reduce administrative burden. Aptarro has expanded its offering through acquisitions including Health eFilings and RCxRules, adding clinical data analytics, automated MIPS reporting, and revenue cycle automation capabilities. The business is commercially established and serves healthcare networks across the United States rather than developing therapeutics or medical products. Its core value proposition is helping healthcare organizations optimize reimbursement accuracy, staff productivity, and financial outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptarro.